Compare Heron Therapeutics Inc (HRTX) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Prologis Inc — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Prologis Inc trades at $151.05 (market cap $137.50B). The key difference: Prologis Inc is far larger — about 1503.4× Heron Therapeutics Inc's market cap, and Prologis Inc pays a 2.9% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PLD | |
|---|---|---|
Market Cap | $91.46M | $137.50B |
Sector | Health | Real Estate |
52-Week High | $1.96 | $149.96 |
52-Week Low | $0.39 | $104.08 |
Enterprise Value | $189.36M | $172.18B |
Dividend Yield | — | 2.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
